Analyst Price Targets — LH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 1, 2026 12:49 pm | Eric Coldwell | Robert W. Baird | $334.00 | $255.97 | TheFly | Labcorp price target raised to $334 from $332 at Baird |
| April 8, 2026 1:14 pm | — | Evercore ISI | $300.00 | $274.72 | TheFly | Labcorp price target raised to $300 from $280 at Evercore ISI |
| February 24, 2026 11:40 am | David Westenberg | Piper Sandler | $300.00 | $285.30 | TheFly | Labcorp price target raised to $300 from $270 at Piper Sandler |
| February 18, 2026 12:48 pm | — | Robert W. Baird | $326.00 | $276.67 | TheFly | Labcorp price target raised to $326 from $313 at Baird |
| January 14, 2026 2:37 pm | — | Robert W. Baird | $313.00 | $259.18 | TheFly | Labcorp price target raised to $313 from $307 at Baird |
| October 29, 2025 12:55 pm | Kevin Caliendo | UBS | $320.00 | $253.74 | TheFly | Labcorp price target lowered to $320 from $325 at UBS |
| October 29, 2025 11:12 am | — | Robert W. Baird | $304.00 | $259.69 | TheFly | Labcorp price target lowered to $304 from $313 at Baird |
| October 28, 2025 5:09 pm | Michael Cherny | Leerink Partners | $342.00 | $261.63 | StreetInsider | Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted' |
| October 17, 2025 12:27 pm | — | UBS | $325.00 | $285.93 | TheFly | Labcorp price target raised to $325 from $305 at UBS |
| October 17, 2025 10:47 am | Ann Hynes | Mizuho Securities | $320.00 | $283.71 | TheFly | Labcorp price target raised to $320 from $285 at Mizuho |
Latest News for LH
Labcorp remains a buy consideration, leveraging a successful rollup strategy in a fragmented laboratory testing industry for steady, predictable growth. Automation is driving cost reductions in LH's operations. That cost reduction helps offset healthcare pricing pressures. With a larger scale, LH now targets single-digit growth and a total return around 10%, prioritizing predictability over rapid expansion.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BURLINGTON, N.C., July 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for those looking for undervalued stocks?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.